FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding Vafseo's label.
Wondering what's happening in today's after-hours session? As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Here are the top movers in Thursday's session. Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Top movers in Thursday's session Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Which stocks are gapping on Thursday? The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Stay updated with the stocks that are on the move in today's pre-market session. Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Stay updated with the stocks that are on the move in today's after-hours session. After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
